← Back
Data updated: Jul 17, 2026
SUNSTAR AMERICAS
Generics Pharmaceuticals
SUNSTAR AMERICAS is a generic drug manufacturer with 1 FDA-approved products.
2005
Since
1
Drugs
-
Trials
0
New Drugs (2yr)
SUNSTAR AMERICAS's Key Drugs
SUNSTAR AMERICAS's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
No active drugs
SUNSTAR AMERICAS's Recent FDA Approvals
New NDA/BLA approvals for SUNSTAR AMERICAS over the last two years — novel drugs only, excluding generics and label supplements.
No recent approvals
SUNSTAR AMERICAS's Therapeutic Areas
Disease areas where SUNSTAR AMERICAS has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
No indication data
SUNSTAR AMERICAS Pipeline Snapshot
Active clinical trials for SUNSTAR AMERICAS across all therapeutic areas, from ClinicalTrials.gov.
No active pipeline data available
Pro Expected Approvals & Milestones
Loading detailed analysis...
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Unlock Full Intelligence
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2005-11-29
- Latest
- 2014-05-02
- Applications
- 1